Paula Alexander

Dr. Paula Alexander

Medical Oncology, The Oncology Institute "Prof Dr. Ion Chiricuta", Cluj-Napoca, Cluj, Romania
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Teodora AlexescuTeodora Alexescu
Teodora Alexescu
Antonia NechitaAntonia Nechita
Antonia Nechita
PAPaula Alexander
Paula Alexander
MPMirela-Georgiana Perné
Mirela-Georgiana Perné
MMMircea Vasile Milaciu
Mircea Vasile Milaciu
OOOlga Hilda Orasan
Olga Hilda Orasan
Background: Diabetes mellitus (DM) is a chronic metabolic disorder significantly associated with cardiovascular complications. Electrocardiographic (ECG) abnormalities are common in patients with type 2 diabetes (T2DM) and can serve as early markers for cardiovascular risk. Objective: This meta-analysis aims to evaluate the impact of T2DM on electrocardiographic changes, focusing on major ECG abnormalities, fragmented QRS (fQRS) complexes, and prolonged corrected QT (QTc) intervals. Materials and Methods: A systematic review of observational studies published between 2017 and 2022 was conducted using databases such as PubMed, Web of Science, Cochrane Library, Embase, and ClinicalTrials.gov. The inclusion criteria required studies to focus on patients with T2DM and report ECG changes. A total of 13 studies comprising 25,530 participants met the criteria and were included in the meta-analysis. The statistical analysis was performed using RevMan 5.4 with a random-effects model. Results: T2DM patients were 1.74 times more likely to develop major ECG abnormalities than non-diabetic individuals (crude OR = 1.74, 95% CI = 1.17–2.57, p = 0.006). The prevalence of fQRS complexes was significantly higher among T2DM patients (crude OR = 2.48, 95% CI = 2.09–2.957, p < 0.00001). Additionally, T2DM patients exhibited a higher likelihood of QTc interval prolongation (crude OR = 1.38, 95% CI = 1.09–1.74, p = 0.008). Conclusions: This meta-analysis demonstrates that T2DM patients have a significantly higher risk of ECG abnormalities, including major changes, fQRS complexes, and prolonged QTc intervals. Regular ECG monitoring is essential for early detection and management of cardiovascular risks in T2DM patients.

28 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
radu vidraradu vidra
radu vidra
PAPaula Alexander
Paula Alexander
GLGabor Liposits
Gabor Liposits
Background/Objective: The global burden of gastrointestinal (GI) cancers is rising sharply among the elderly, with a projected doubling of incidence and mortality by 2050. Given the heterogeneity of aging and the limitations of traditional performance scales such as ECOG or KPS, integrating geriatric assessment (GA) into oncology has become essential for tailoring safe and effective treatment strategies in this population. This paper provides a practical framework for implementing geriatric assessment and management (GAM) in GI oncology, particularly in resource-limited settings, and highlights validated screening instruments suitable for clinical integration. Methods: A systematic search was performed across PubMed, Scopus, and Web of Science databases for publications between January 2019 and August 2025 using combinations of the keywords geriatric assessment, gastrointestinal cancer, frailty screening, elderly, oncology, and comprehensive geriatric assessment. International and regional clinical practice guidelines from ASCO, ESMO, and SIOG were reviewed in detail. Articles were included when they addressed validated screening tools, oncology focused strategies, or clinical outcomes associated with GA-based interventions. Studies focusing exclusively on non-oncologic geriatric populations were excluded. Relevant data were extracted regarding study design, population, tool validation, predictive performance, and feasibility. Results: GA improves prediction of treatment-related toxicity, supports individualized treatment planning, and enhances quality of life and functional outcomes. Two-step screening approaches, initial frailty screening followed by comprehensive geriatric assessment for those with positive results, were found most effective. Practical GA models and telehealth-based applications were identified as feasible even in low- and middle-income contexts. Conclusions: Integrating GA into GI oncology fosters patient-centered, evidence-based care that optimizes treatment tolerance, reduces complications, and aligns therapeutic goals with patient values. Institutional commitment, interdisciplinary collaboration, and targeted training are pivotal for establishing GA as a standard of care across diverse healthcare settings.